BioSpace News Archive

uLab Systems, the creator of the breakthrough orthodontic aligner movement planning software, has passed a significant commercial milestone with over 6,000 cases completed in just 6 months.

Accountable Care Organizations Have Shown Reduced Costs and Improved Care

You could say the beauty biz was in her DNA.

Notable Labs, a startup that accelerates drug development by matching drugs with patients who are most likely to respond, announced today that it has launched its first drug development program, ND-1000, which targets pediatric and adult blood cancers.

Shield Therapeutics plc (LSE:STX), a commercial stage, pharmaceutical company with an initial focus on addressing iron deficiency, is pleased to announce the appointment of James Karis as non-executive Chairman of the Company with immediate effect.

Sciad Newswire / Hypha Discovery Limited, a leading microbial biotechnology company specialising in biocatalytic solutions for pharmaceutical and agricultural R&D companies, has launched its new line of PolyCYPs® kits

Pulmonary fibrosis patients, their loved ones and care team can now connect through a platform jointly launched by the Pulmonary Fibrosis Foundation (PFF) and Responsum Health.

Appointment bolsters Neurogene’s mission to bring life-changing therapies to patients with rare neurological disorders

World-Renowned Expert Assumes New Leadership Role at VDI

Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to lead product candidate A4250, an ileal bile acid transporter (IBAT) inhibitor, for the treatment of biliary atresia, a rare and life-threatening liver disease with no approved pharmacologic treatment option.